Paget's disease genetic markers

submit enquiry
DNA strand (c) iStock
DNA strand (c) iStock

University: University of Edinburgh

Sector(s): Life Sciences, Healthcare & Pharmaceuticals

About Opportunity:

These genetic markers have an identified association with the individual prediction of susceptibility and severity of Paget's disease of the bone.

This technology focuses on genetic markers linked to individual prediction of susceptibility and severity of Paget's disease of the bone.

The technology consists of single nucleotide polymorphisms (SNPs) associated with prediction of Paget’s disease susceptibility and severity. Identifying individuals who carry the mutations will allow for close monitoring of disease development, and subsequent therapeutic intervention.

Similarly, predicted extent of severity will help inform on the level of patient monitoring and potential prophylactic therapy administration.

Key Benefits:

  • Biomarkers shown to predict susceptibility to Paget’s disease
  • Biomarkers shown to predict the likely severity of the disease
  • Biomarkers identified from large scale clinical studies of 737 to 1940 patients


  • Diagnostic for identifying individuals at risk of developing Paget’s disease as well prediction of disease severity

IP Status:

This technology is available to access under the University of Edinburgh's Open Technology initiative.

Patent publication document (Reference WO2011128646A2), detailing invention, methods and results, will be provided following acceptance of the University's Open Technology standard terms and conditions.

It would help speed up access to this technology if you confirm acceptance of the published terms and conditions in the enquiry form below, indicating your proposed use for this technology.


Please enter your name.

Please enter the name of the company you work for.

Is your company an SME?

Please select the country you are in.

Please select what part of the UK you are in.

Please select from the following options.

Please enter your email address.

To help us process your enquiry faster please enter some details about the information you are interested in.

Words remaining:

Related Opportunities

  • Lab in a Pill

    Scientists at the University of Glasgow have pioneered a new sensor technology, Lab-in-a-Pill, that could have major impact on the cost and effectiveness of bowel cancer treatment.

    Expires: Created:
  • Thermoelectric Sensor

    The Thermoelectric Sensor technology is a Nano-Calorimetric Sensor which measures very small changes in temperature. The IP provides a route to making the most sensitive calorimetric measurements (with a resolution of 0.1 mK).

    Expires: Created:
  • Parkinson's Disease Model

    The University of Glasgow is offering an exciting new model for the evaluation of new treatments for Parkinsons disease

    Expires: Created:
  • Combination Treatment for MRSA Nasal Carriage and MRSA-infected Wounds

    The new treatment is a combination of a peptide (ranalexin) with bacteria cell wall-digesting protein (lysostaphin), which specifically targets and kills Staphylococcus aureus, including MRSA.

    Expires: Created:
  • Synergistic antifungal combination

    Candida species are a major cause of catheter-related nosocomial bloodstream infections. We have identified that the combination of an echinocandin antifungal with certain antimicrobial peptides results in potent, synergistic inhibition of yeast pathogens in vitro, so offering a potential combinatio...

    Expires: Created:

Alerts Signup

Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities

Register Now for University Alerts

Search Filter

Share this page

Use the buttons below to share these technology opportunities on your favourite social networking site. You can also share them from inside the individual opportunity.